These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10362395)

  • 1. Nitric oxide synthase inhibitors--a mechanism-based treatment of septic shock.
    Kilbourn R
    Crit Care Med; 1999 May; 27(5):857-8. PubMed ID: 10362395
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red.
    Cobb JP
    Crit Care Med; 1999 May; 27(5):855-6. PubMed ID: 10362394
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitric oxide synthase inhibition in septic shock--a question of the right time, the right drug, and the right model?
    Bone HG
    Crit Care Med; 1998 Dec; 26(12):1945-7. PubMed ID: 9875895
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitric oxide and septic shock.
    Cobb JP; Danner RL
    JAMA; 1996 Apr; 275(15):1192-6. PubMed ID: 8609688
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of methylene blue in sepsis: a systematic review.
    Kwok ES; Howes D
    J Intensive Care Med; 2006; 21(6):359-63. PubMed ID: 17095500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.
    Grover R; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL
    Crit Care Med; 1999 May; 27(5):913-22. PubMed ID: 10362413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nitric-oxide synthase inhibitor treatment in septic shock].
    Møller K; Skinhøj P
    Ugeskr Laeger; 2004 Mar; 166(11):1028-9. PubMed ID: 15049244
    [No Abstract]   [Full Text] [Related]  

  • 9. Administration of nitric oxide synthase inhibitor 546C88 in septic shock.
    Renes MH; van der Hoeven JG
    Crit Care Med; 2004 Jul; 32(7):1625; author reply 1625-6. PubMed ID: 15241124
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospects for management of peripheral vascular failure in septic shock.
    Allen JD; Herity NA
    Br J Anaesth; 1996 Feb; 76(2):177-8. PubMed ID: 8777093
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
    Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA
    Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular derangement in septic shock and nitric oxide.
    Lodato RF
    J Crit Care; 1996 Dec; 11(4):151-4. PubMed ID: 8977990
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.
    Wolfe TA; Dasta JF
    Ann Pharmacother; 1995 Jan; 29(1):36-46. PubMed ID: 7536056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yet another potential role for nitric oxide in the pathophysiology of septic shock.
    Sheehan M; Wong HR
    Crit Care Med; 2002 Jun; 30(6):1393-4. PubMed ID: 12072706
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is use of nitric oxide (NO) synthase inhibitors justified for therapy of septic shock?].
    Jonderko G; Marcisz C; Braclik M
    Postepy Hig Med Dosw; 2003; 57(1):67-90. PubMed ID: 12765124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of the activity of inducible nitric oxide synthase in septic shock.
    Thiemermann C
    Prog Clin Biol Res; 1995; 392():383-92. PubMed ID: 8524946
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitric oxide synthase inhibition as therapy for sepsis: a decade of promise.
    Cobb JP
    Surg Infect (Larchmt); 2001; 2(2):93-100; discussion 100-1. PubMed ID: 12594864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitric oxide donors and nitric oxide synthase inhibitors in neonatal rat endotoxic shock.
    Cochran JB; Genovese F; Ogura S; Teti G; Cook JA
    Biochem Pharmacol; 1999 Aug; 58(4):687-91. PubMed ID: 10413307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is nitric oxide overproduction the target of choice for the management of septic shock?
    Feihl F; Waeber B; Liaudet L
    Pharmacol Ther; 2001 Sep; 91(3):179-213. PubMed ID: 11744067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.